Cover Image
Market Research Report
Product code 
1068737

Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2022-2026
Published: March 31, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the anti-CD20 monoclonal antibodies (mABs) market and it is poised to grow by $ 9.05 bn during 2022-2026 progressing at a CAGR of 9.81% during the forecast period. Our report on the anti-cd20 monoclonal antibodies (mABs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased use of combination therapies, high target affinity and specificity of anti-CD20 mABs, and strong pipeline and recent approvals.

The anti-cd20 monoclonal antibodies (mABs) market analysis includes product segment and geographic landscape.

Technavio's anti-CD20 monoclonal antibodies (mABs) market is segmented as below:

By Product

  • Oncology
  • Neurology
  • Immunology

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing awareness about therapeutic areas as one of the prime reasons driving the anti-cd20 monoclonal antibodies (mABs) market growth during the next few years. Also, the presence of reimbursement and patient assistance programs, and the development of CD20 bispecific antibodies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the anti-CD20 monoclonal antibodies (mABs) market covers the following areas:

  • Anti-CD20 monoclonal antibodies (mABs) market sizing
  • Anti-CD20 monoclonal antibodies (mABs) market forecast
  • Anti-CD20 monoclonal antibodies (mABs) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-CD20 monoclonal antibodies (mABs) market vendors that include Acrotech Biopharma, Amgen Inc., AstraZeneca Plc, Celltrion Healthcare Co. Ltd., F. Hoffmann La Roche Ltd., Fosun International Ltd., Genmab AS, IGM Biosciences Inc., JSC BIOCAD, LFB SA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Spectrum Pharmaceuticals Inc., TG Therapeutics Inc., United BioPharma Inc., and ZHEJIANG HISUN PHARMACEUTICAL Co. Ltd. Also, the anti-CD20 monoclonal antibodies (mABs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73017

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Oncology - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
  • 5.4 Neurology - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Neurology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Neurology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Neurology - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Neurology - Year-over-year growth 2021-2026 (%)
  • 5.5 Immunology - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Immunology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Immunology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Immunology - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Immunology - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Product
  • Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 Mexico - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Mexico - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Mexico - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 UK - Market size and forecast 2021-2026
  • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Acrotech Biopharma
  • Exhibit 89: Acrotech Biopharma - Overview
  • Exhibit 90: Acrotech Biopharma - Product / Service
  • Exhibit 91: Acrotech Biopharma - Key offerings
  • 10.4 Amgen Inc.
  • Exhibit 92: Amgen Inc. - Overview
  • Exhibit 93: Amgen Inc. - Product / Service
  • Exhibit 94: Amgen Inc. - Key offerings
  • 10.5 Celltrion Healthcare Co. Ltd.
  • Exhibit 95: Celltrion Healthcare Co. Ltd. - Overview
  • Exhibit 96: Celltrion Healthcare Co. Ltd. - Product / Service
  • Exhibit 97: Celltrion Healthcare Co. Ltd. - Key offerings
  • 10.6 F. Hoffmann La Roche Ltd.
  • Exhibit 98: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 99: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 100: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 101: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 102: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.7 IGM Biosciences Inc.
  • Exhibit 103: IGM Biosciences Inc. - Overview
  • Exhibit 104: IGM Biosciences Inc. - Product / Service
  • Exhibit 105: IGM Biosciences Inc. - Key offerings
  • 10.8 LFB SA
  • Exhibit 106: LFB SA - Overview
  • Exhibit 107: LFB SA - Product / Service
  • Exhibit 108: LFB SA - Key offerings
  • 10.9 Novartis AG
  • Exhibit 109: Novartis AG - Overview
  • Exhibit 110: Novartis AG - Business segments
  • Exhibit 111: Novartis AG - Key offerings
  • Exhibit 112: Novartis AG - Segment focus
  • 10.10 Pfizer Inc.
  • Exhibit 113: Pfizer Inc. - Overview
  • Exhibit 114: Pfizer Inc. - Product / Service
  • Exhibit 115: Pfizer Inc. - Key news
  • Exhibit 116: Pfizer Inc. - Key offerings
  • 10.11 Regeneron Pharmaceuticals Inc.
  • Exhibit 117: Regeneron Pharmaceuticals Inc. - Overview
  • Exhibit 118: Regeneron Pharmaceuticals Inc. - Product / Service
  • Exhibit 119: Regeneron Pharmaceuticals Inc. - Key offerings
  • 10.12 TG Therapeutics Inc.
  • Exhibit 120: TG Therapeutics Inc. - Overview
  • Exhibit 121: TG Therapeutics Inc. - Product / Service
  • Exhibit 122: TG Therapeutics Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 123: Inclusions checklist
  • Exhibit 124: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 125: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 126: Research methodology
  • Exhibit 127: Validation techniques employed for market sizing
  • Exhibit 128: Information sources
  • 11.5 List of abbreviations
  • Exhibit 129: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Neurology - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Neurology - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Neurology - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Neurology - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Immunology - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Immunology - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Immunology - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Immunology - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Product ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Mexico - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Mexico - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Acrotech Biopharma - Overview
  • Exhibits90: Acrotech Biopharma - Product / Service
  • Exhibits91: Acrotech Biopharma - Key offerings
  • Exhibits92: Amgen Inc. - Overview
  • Exhibits93: Amgen Inc. - Product / Service
  • Exhibits94: Amgen Inc. - Key offerings
  • Exhibits95: Celltrion Healthcare Co. Ltd. - Overview
  • Exhibits96: Celltrion Healthcare Co. Ltd. - Product / Service
  • Exhibits97: Celltrion Healthcare Co. Ltd. - Key offerings
  • Exhibits98: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits99: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits100: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits101: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits102: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits103: IGM Biosciences Inc. - Overview
  • Exhibits104: IGM Biosciences Inc. - Product / Service
  • Exhibits105: IGM Biosciences Inc. - Key offerings
  • Exhibits106: LFB SA - Overview
  • Exhibits107: LFB SA - Product / Service
  • Exhibits108: LFB SA - Key offerings
  • Exhibits109: Novartis AG - Overview
  • Exhibits110: Novartis AG - Business segments
  • Exhibits111: Novartis AG - Key offerings
  • Exhibits112: Novartis AG - Segment focus
  • Exhibits113: Pfizer Inc. - Overview
  • Exhibits114: Pfizer Inc. - Product / Service
  • Exhibits115: Pfizer Inc. - Key news
  • Exhibits116: Pfizer Inc. - Key offerings
  • Exhibits117: Regeneron Pharmaceuticals Inc. - Overview
  • Exhibits118: Regeneron Pharmaceuticals Inc. - Product / Service
  • Exhibits119: Regeneron Pharmaceuticals Inc. - Key offerings
  • Exhibits120: TG Therapeutics Inc. - Overview
  • Exhibits121: TG Therapeutics Inc. - Product / Service
  • Exhibits122: TG Therapeutics Inc. - Key offerings
  • Exhibits123: Inclusions checklist
  • Exhibits124: Exclusions checklist
  • Exhibits125: Currency conversion rates for US$
  • Exhibits126: Research methodology
  • Exhibits127: Validation techniques employed for market sizing
  • Exhibits128: Information sources
  • Exhibits129: List of abbreviations